(Institución)
 
 

Docu-menta >

Statistics

Total Visits

Views
Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment 324

Total Visits per Month

August 2025 September 2025 October 2025 November 2025 December 2025 January 2026 February 2026
Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment 20 15 20 22 14 7 1

File Downloads

Views
23. Navarro- MOL THERAPY MCD 2021.pdf 180

Top Country Views

Views
España 324

Top City Views

Views
Madrid 324

 

Información y consultas: documenta@ciemat.es | Documento legal